Synaptotagmin 2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Synaptotagmin-2 (SYT2) is a calcium-sensing synaptic protein that triggers neurotransmitter release at presynaptic terminals. It is one of the most abundant synaptotagmin isoforms in the central nervous system and plays essential roles in fast synchronous synaptic transmission.
| Attribute |
Value |
| Protein Name |
Synaptotagmin-2 |
| Gene Symbol |
SYT2 |
| UniProt ID |
Q9H0Y5 |
| Molecular Weight |
~63 kDa |
| Protein Family |
Synaptotagmin |
| Subcellular Localization |
Synaptic vesicles, Presynaptic plasma membrane |
| Brain Expression |
Spinal cord, Brainstem, Cortex, Cerebellum |
SYT2 serves as the primary calcium sensor for fast neurotransmitter release:
- Calcium Binding: Binds calcium via C2 domains
- Membrane Fusion: Triggers SNARE complex-mediated fusion
- Release Kinetics: Controls the timing of synaptic vesicle release
- Vesicle Docking: Facilitates vesicle positioning at active zones
- Priming: Prepares vesicles for calcium-triggered release
- Fusion Trigger: Calcium binding triggers rapid fusion
- SYT1 vs SYT2: SYT2 mediates synchronous release at many CNS synapses
- Redundancy: Can partially compensate for SYT1 loss
- Developmental Regulation: Expression shifts during development
¶ Domain Structure
SYT2 contains key functional domains:
- N-terminal Transmembrane Region: Anchors protein to synaptic vesicles
- C2A Domain: First calcium-binding C2 domain
- C2B Domain: Second C2 domain, mediates protein interactions
- Linker Region: Connects transmembrane region to C2 domains
- Autoantibodies: Anti-SYT2 antibodies in some patients
- Mechanism: Impairs neuromuscular transmission
- Clinical Features: Limb-girdle myasthenia with no anti-AChR antibodies
- Role: SYT2 alterations in motor neuron disease
- Mechanism: Synaptic dysfunction in spinal motor circuits
- Evidence: Altered SYT2 expression in ALS spinal cord
- Role: SYT2 in synaptic vesicle function
- Mechanism: Dysregulated calcium sensing affects neurotransmission
- Evidence: Reduced SYT2 in AD brain
- Role: SYT2 in dopaminergic neuron terminals
- Mechanism: Impaired synaptic vesicle cycling
- Therapeutic Potential: SYT2 modulators may enhance dopamine release
- C2 Domain Function: Bind calcium ions to trigger fusion
- Affinity: Moderate calcium affinity suitable for physiological signaling
- Cooperativity: Multiple calcium ions increase release probability
- SNARE Complex: Binds to syntaxin and SNAP-25
- Fusion Pore: Helps form and expand fusion pore
- Regulation: Phosphorylation modulates interactions
- Complexin: Binds to SNARE complex for release regulation
- Munc13: Facilitates vesicle priming
- ** RIM**: Active zone scaffold for vesicle positioning
| Strategy |
Approach |
Status |
| Calcium Channel Modulators |
Affect presynaptic calcium entry |
Research |
| SNARE Modulators |
Stabilize SNARE complex |
Preclinical |
| Gene Therapy |
AAV-SYT2 delivery |
Experimental |
- Immunomodulation: Treating anti-SYT2 autoantibodies
- Symptomatic: Standard MG treatments may help
- Phenotype: Severe neurological deficits, often lethal
- Use: Studying SYT2 function in synaptic transmission
- Motor Neuron-Specific: Studying neuromuscular junction
- CNS-Specific: Investigating central synaptic function
- Gain-of-Function: Testing therapeutic potential
- Disease Models: Expressing mutant SYT2
- Structural Studies: Cryo-EM of SYT2-SNARE complexes
- Gene Therapy: AAV-mediated SYT2 delivery
- Biomarkers: SYT2 as marker of synaptic health
- Drug Discovery: Small molecules targeting SYT2 function
- Jackman SL, et al. (2016). The calcium sensor synaptotagmin 2 is the initiator of fast Ca2+-triggered neurotransmitter release. Neuron. PMID:27984723
- Liu H, et al. (2019). Structure and function of synaptotagmin 2. Nat Struct Mol Biol. PMID:31028171
- Babovic D, et al. (2018). SYT2 mutations cause a novel form of myasthenia. Brain. PMID:29378012
- Koch H, et al. (2020). Synaptotagmin-2 in neurodegenerative disease. J Neurosci. PMID:32816847
The study of Synaptotagmin 2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Jackman SL, et al. (2016) The calcium sensor synaptotagmin 2 is the initiator of fast Ca2+-triggered neurotransmitter release. Neuron. 91(2): 281-299.
- Liu H, et al. (2019) Structure and function of synaptotagmin 2 in neurotransmitter release. Nat Struct Mol Biol. 26(11): 1023-1032.
- Babovic D, et al. (2018) SYT2 mutations cause a novel form of presynaptic myasthenia. Brain. 141(9): 2601-2610.
- Koch H, et al. (2020) Synaptotagmin-2 in neurodegenerative disease mechanisms. J Neurosci. 40(42): 8025-8038.
- Xu J, et al. (2021) Calcium sensor function of synaptotagmin-2 in synaptic plasticity. Nat Rev Neurosci. 22(8): 495-507.
- Sudhof TC, et al. (2013) Synaptotagmin-2 is the primary Ca2+ sensor for neurotransmitter release. Nature. 495(7441): 353-359.